We serve Chemical Name:5-bromo-6-cyanopyridine-2-carboxylic acid CAS:959741-34-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-bromo-6-cyanopyridine-2-carboxylic acid
CAS.NO:959741-34-5
Synonyms:5-bromo-6-cyano-pyridine-2-carboxylic acid;5-Bromo-6-cyanopicolinic acid
Molecular Formula:C7H3BrN2O2
Molecular Weight:227.01500
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:73.98000
Exact Mass:225.93800
LogP:1.41398
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-bromo-6-cyano-pyridine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-6-cyanopicolinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-6-cyano-pyridine-2-carboxylic acid Use and application,5-bromo-6-cyano-pyridine-2-carboxylic acid technical grade,usp/ep/jp grade.
Related News: Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. 5-bromo-6-cyanopyridine-2-carboxylic acid manufacturer ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 5-bromo-6-cyanopyridine-2-carboxylic acid supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-bromo-6-cyanopyridine-2-carboxylic acid vendor British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. 5-bromo-6-cyanopyridine-2-carboxylic acid factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.
